336 related articles for article (PubMed ID: 24492294)
1. High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.
Liu Y; Caffry I; Wu J; Geng SB; Jain T; Sun T; Reid F; Cao Y; Estep P; Yu Y; Vásquez M; Tessier PM; Xu Y
MAbs; 2014; 6(2):483-92. PubMed ID: 24492294
[TBL] [Abstract][Full Text] [Related]
2. An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies.
Estep P; Caffry I; Yu Y; Sun T; Cao Y; Lynaugh H; Jain T; Vásquez M; Tessier PM; Xu Y
MAbs; 2015; 7(3):553-61. PubMed ID: 25790175
[TBL] [Abstract][Full Text] [Related]
3. Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties.
Starr CG; Makowski EK; Wu L; Berg B; Kingsbury JS; Gokarn YR; Tessier PM
Mol Pharm; 2021 Jul; 18(7):2744-2753. PubMed ID: 34105965
[TBL] [Abstract][Full Text] [Related]
4. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
[TBL] [Abstract][Full Text] [Related]
5. Facile Preparation of Stable Antibody-Gold Conjugates and Application to Affinity-Capture Self-Interaction Nanoparticle Spectroscopy.
Geng SB; Wu J; Alam ME; Schultz JS; Dickinson CD; Seminer CR; Tessier PM
Bioconjug Chem; 2016 Oct; 27(10):2287-2300. PubMed ID: 27494306
[TBL] [Abstract][Full Text] [Related]
6. Discovery of highly soluble antibodies prior to purification using affinity-capture self-interaction nanoparticle spectroscopy.
Wu J; Schultz JS; Weldon CL; Sule SV; Chai Q; Geng SB; Dickinson CD; Tessier PM
Protein Eng Des Sel; 2015 Oct; 28(10):403-14. PubMed ID: 26363633
[TBL] [Abstract][Full Text] [Related]
7. Plasmonic measurements of monoclonal antibody self-association using self-interaction nanoparticle spectroscopy.
Jayaraman J; Wu J; Brunelle MC; Cruz AM; Goldberg DS; Lobo B; Shah A; Tessier PM
Biotechnol Bioeng; 2014 Aug; 111(8):1513-20. PubMed ID: 25097914
[TBL] [Abstract][Full Text] [Related]
8. Measurements of Monoclonal Antibody Self-Association Are Correlated with Complex Biophysical Properties.
Geng SB; Wittekind M; Vigil A; Tessier PM
Mol Pharm; 2016 May; 13(5):1636-45. PubMed ID: 27045771
[TBL] [Abstract][Full Text] [Related]
9. High-throughput assay for measuring monoclonal antibody self-association and aggregation in serum.
Li X; Geng SB; Chiu ML; Saro D; Tessier PM
Bioconjug Chem; 2015 Mar; 26(3):520-8. PubMed ID: 25714504
[TBL] [Abstract][Full Text] [Related]
10. Application of Affinity-Capture Self-Interaction Nanoparticle Spectroscopy in Predicting Protein Stability, Especially for Co-Formulated Antibodies.
Zhou M; Yan Z; Li H; Liu X; Sun P
Pharm Res; 2021 Apr; 38(4):721-732. PubMed ID: 33754257
[TBL] [Abstract][Full Text] [Related]
11. An accelerated surface-mediated stress assay of antibody instability for developability studies.
Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P
MAbs; 2020; 12(1):1815995. PubMed ID: 32954930
[TBL] [Abstract][Full Text] [Related]
12. Rapid analysis of antibody self-association in complex mixtures using immunogold conjugates.
Sule SV; Dickinson CD; Lu J; Chow CK; Tessier PM
Mol Pharm; 2013 Apr; 10(4):1322-31. PubMed ID: 23383873
[TBL] [Abstract][Full Text] [Related]
13. High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice.
Kelly RL; Sun T; Jain T; Caffry I; Yu Y; Cao Y; Lynaugh H; Brown M; Vásquez M; Wittrup KD; Xu Y
MAbs; 2015; 7(4):770-7. PubMed ID: 26047159
[TBL] [Abstract][Full Text] [Related]
14. A novel screening method to assess developability of antibody-like molecules.
Kohli N; Jain N; Geddie ML; Razlog M; Xu L; Lugovskoy AA
MAbs; 2015; 7(4):752-8. PubMed ID: 25961854
[TBL] [Abstract][Full Text] [Related]
15. High-throughput analysis of concentration-dependent antibody self-association.
Sule SV; Sukumar M; Weiss WF; Marcelino-Cruz AM; Sample T; Tessier PM
Biophys J; 2011 Oct; 101(7):1749-57. PubMed ID: 21961601
[TBL] [Abstract][Full Text] [Related]
16. High-throughput profiling of antibody self-association in multiple formulation conditions by PEG stabilized self-interaction nanoparticle spectroscopy.
Phan S; Walmer A; Shaw EW; Chai Q
MAbs; 2022; 14(1):2094750. PubMed ID: 35830420
[TBL] [Abstract][Full Text] [Related]
17. Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries.
Azevedo Reis Teixeira A; Erasmus MF; D'Angelo S; Naranjo L; Ferrara F; Leal-Lopes C; Durrant O; Galmiche C; Morelli A; Scott-Tucker A; Bradbury ARM
MAbs; 2021; 13(1):1980942. PubMed ID: 34850665
[TBL] [Abstract][Full Text] [Related]
18. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
[TBL] [Abstract][Full Text] [Related]
19. Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics.
Avery LB; Wade J; Wang M; Tam A; King A; Piche-Nicholas N; Kavosi MS; Penn S; Cirelli D; Kurz JC; Zhang M; Cunningham O; Jones R; Fennell BJ; McDonnell B; Sakorafas P; Apgar J; Finlay WJ; Lin L; Bloom L; O'Hara DM
MAbs; 2018; 10(2):244-255. PubMed ID: 29271699
[TBL] [Abstract][Full Text] [Related]
20. Reduction of therapeutic antibody self-association using yeast-display selections and machine learning.
Makowski EK; Chen H; Lambert M; Bennett EM; Eschmann NS; Zhang Y; Zupancic JM; Desai AA; Smith MD; Lou W; Fernando A; Tully T; Gallo CJ; Lin L; Tessier PM
MAbs; 2022; 14(1):2146629. PubMed ID: 36433737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
